explore -WSS

explore

author：knowledge 2025-10-01 12:34:56 - browse：39

Diversity in clinical trials concept — Adobe

The persistent lack of diversity among participants in clinical trials is a critical issue that is harming both populations that have long been left out of pivotal medical studies and the entire biomedical research enterprise, according to the authors of a report released Tuesday by the National Academies of Sciences, Engineering and Medicine.

Describing the need to move away from trials that focus largely on white men as “urgent,” the report’s authors called for a paradigm shift that gives less power to institutions that fund and conduct clinical research and more to communities under study. The sternly worded report said funding to include and recruit more diverse participants should be a priority that is enforced and said such investments could eventually lead to massive cost savings as the nation’s health disparities are reduced.

“An equitable clinical research enterprise would include trials and studies that match the demographics of the disease burden under study,” the report said. “However, we remain far from achieving this goal.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Surgery pushed Ben Carson to fame

leisure time

WSS

340B reform proposal comes out of Senate working group

Surgery pushed Ben Carson to fame

Gene therapy for Afghan refugees’ infant will be fully covered

Medicare Advantage enrollment hits roughly 33.4 million

Updated Covid vaccine has 54% effectiveness, new study suggests

Medicare Advantage enrollment hits roughly 33.4 million

knowledge

explore

hotspot

Medical records are filled with copy

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Heart attack and stroke risk calculators need revising

Bernie brings in new pharma CEOs to talk drug prices

Dobbs anniversary: the lost opportunity of abortion as health care

Padmanee Sharma of MD Anderson at center of lawsuit over credit

After affirmative action ruling, medical educators look to 'holistic review'

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

In Memoriam: Notable people who died in 2023

In 'major milestone,' FDA approves first cell therapy for solid tumors

focus

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Updated Covid vaccine has 54% effectiveness, new study suggests

New study raises questions about niacin and heart health

What’s missing from the debate over nursing home staff minimums

Updated Covid vaccine has 54% effectiveness, new study suggests

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

hotspot

leisure time

explore

explore